Recent studies demonstrated the fibrosis mediated by NF-κB activation in multiple diseases including cardiac hypertrophy and idiopathic pulmonary fibrosis, and the inhibitions of such pathways prevented excessive ECM deposition and remodeling (Kumar et al., 2011; Song et al., 2016). This evidence concerns the gene NFKB1 and cardiac hypertrophy.